These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15256871)

  • 21. Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population?
    Hałoń A; Patrzałek D; Rabczyński J
    Transplant Proc; 2006; 38(1):193-5. PubMed ID: 16504700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
    Hu RH; Lee PH; Yu SC; Sheu JC; Lai MY
    Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An approach to the rational use of steatotic donor livers in liver transplantation.
    Urena MA; Moreno Gonzalez E; Romero CJ; Ruiz-Delgado FC; Moreno Sanz C
    Hepatogastroenterology; 1999; 46(26):1164-73. PubMed ID: 10370686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Predictive Value of the Maximal Liver Function Capacity Test for the Isolation of Primary Human Hepatocytes.
    Major RD; Kluge M; Jara M; Nösser M; Horner R; Gassner J; Struecker B; Tang P; Lippert S; Reutzel-Selke A; Geisel D; Denecke T; Stockmann M; Pratschke J; Sauer IM; Raschzok N
    Tissue Eng Part C Methods; 2018 Mar; 24(3):179-186. PubMed ID: 29382276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and cultivation of porcine hepatocytes for extracorporeal artificial liver support system.
    Zhou X; Liu L; Kano J; Mukaiyama T; Tokiwa T
    Chin Med J (Engl); 2001 Sep; 114(9):946-9. PubMed ID: 11780388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury.
    Baskin-Bey ES; Canbay A; Bronk SF; Werneburg N; Guicciardi ME; Nyberg SL; Gores GJ
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G396-402. PubMed ID: 15472011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rat hepatocytes isolated from alcohol-induced fatty liver have an increased sensitivity to anoxic injury.
    Caraceni P; Ryu HS; Subbotin V; De Maria N; Colantoni A; Roberts L; Trevisani F; Bernardi M; Van Thiel DH
    Hepatology; 1997 Apr; 25(4):943-9. PubMed ID: 9096602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological approaches to the purification of putative premalignant hepatocytes from genotypic mosaic rat livers.
    Hunt JM; Buckley MT; Laishes BA; Dunsford HA
    Cancer Res; 1985 May; 45(5):2226-33. PubMed ID: 2859107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porcine hepatocytes from slaughterhouse organs. An unlimited resource for bioartificial liver devices.
    Koebe HG; Pahernik SA; Sproede M; Thasler WE; Schildberg FW
    ASAIO J; 1995; 41(2):189-93. PubMed ID: 7640425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model.
    Jamieson RW; Zilvetti M; Roy D; Hughes D; Morovat A; Coussios CC; Friend PJ
    Transplantation; 2011 Aug; 92(3):289-95. PubMed ID: 21681143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryopreserved human hepatocytes from cell bank: in vitro function and clinical application.
    Baccarani U; Sanna A; Cariani A; Sainz M; Adani GL; Lorenzin D; Montanaro D; Scalamogna M; Piccolo G; Risaliti A; Bresadola F; Donini A
    Transplant Proc; 2005; 37(1):256-9. PubMed ID: 15808612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model.
    Kawahara T; Toso C; Douglas DN; Nourbakhsh M; Lewis JT; Tyrrell DL; Lund GA; Churchill TA; Kneteman NM
    Liver Transpl; 2010 Aug; 16(8):974-82. PubMed ID: 20677288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of steatosis on drug-metabolizing capability of primary human hepatocytes.
    Donato MT; Jiménez N; Serralta A; Mir J; Castell JV; Gómez-Lechón MJ
    Toxicol In Vitro; 2007 Mar; 21(2):271-6. PubMed ID: 16950596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired.
    Cho JY; Suh KS; Kwon CH; Yi NJ; Lee KU
    Surgery; 2006 Apr; 139(4):508-15. PubMed ID: 16627060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor liver steatosis and graft selection for liver transplantation: a short review.
    Angelico M
    Eur Rev Med Pharmacol Sci; 2005; 9(5):295-7. PubMed ID: 16231593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer.
    Osada S; Matsui S; Komori S; Yamada J; Sanada Y; Ihawa A; Tanaka Y; Tokuyama Y; Okumura N; Nonaka K; Hosono Y; Takahashi T; Yamaguchi K; Yoshida K
    Hepatogastroenterology; 2010; 57(97):76-80. PubMed ID: 20422876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An algorithm that predicts the viability and the yield of human hepatocytes isolated from remnant liver pieces obtained from liver resections.
    Lee SM; Schelcher C; Laubender RP; Fröse N; Thasler RM; Schiergens TS; Mansmann U; Thasler WE
    PLoS One; 2014; 9(10):e107567. PubMed ID: 25313881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.